HealthDay – MONDAY, May 25 (HealthDay News) — The use of the drug bevacizumab
(Avastin) in combination with chemotherapy greatly increases the risk of
gastrointestinal perforations in cancer patients, new research has
found.
Read more
MyDD :: All Stories
a Home Remedy for Yeast Infection

Related posts:

1. Cancer Drug May Boost Risk of Gastrointestinal Perforation (HealthDay) HealthDay - MONDAY, May 25 (HealthDay News) -- The use...
2. Cancer Drug May Boost Risk of Gastrointestinal Perforation (HealthDay) HealthDay - MONDAY, May 25 (HealthDay News) -- The use...
3. Arena: compliant trial patients lost more weight (Reuters) Reuters - Arena Pharmaceuticals Inc on Saturday said patients who...
4. FDA to Study Ways to Be More Open With Public (HealthDay) HealthDay - TUESDAY, June 2 (HealthDay News) -- The U.S....
5. Broad-Spectrum Cervical Cancer Vaccine Shows Promise (HealthDay) HealthDay - TUESDAY, May 26 (HealthDay News) -- An investigational...

Related posts brought to you by Yet Another Related Posts Plugin.

This entry was posted on Sunday, June 7th, 2009 at 12:22 pm and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.